Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M513587200 on April 11, 2006

J. Biol. Chem., Vol. 281, Issue 23, 16034-16042, June 9, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/23/16034    most recent
M513587200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ming, L.
Right arrow Articles by Zhang, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ming, L.
Right arrow Articles by Zhang, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PUMA Dissociates Bax and Bcl-XL to Induce Apoptosis in Colon Cancer Cells*

Lihua Ming{ddagger}, Peng Wang§, Alexander Bank§, Jian Yu{ddagger}, and Lin Zhang§1

From the Departments of {ddagger}Pathology and §Pharmacology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15213

PUMA is a BH3-only Bcl-2 family protein that plays an essential role in DNA damage-induced apoptosis. PUMA interacts with anti-apoptotic Bcl-2 and Bcl-XL and is dependent on Bax to induce apoptosis. In this study, we investigated how the interactions of PUMA with the antiapoptotic proteins coordinate with Bax to initiate apoptosis in HCT116 colon cancer cells. We found that Bcl-XL was most effective among several antiapoptotic proteins in suppressing PUMA-induced apoptosis and PUMA-dependent apoptosis induced by the DNA-damaging agent adriamycin. Mutant Bcl-XL that cannot interact with Bax was unable to protect cells from PUMA-mediated apoptosis. Knockdown of Bcl-XL by RNA interference significantly enhanced PUMA-mediated apoptosis in HCT116 cells but not in PUMA-knockout cells. Furthermore, Bax was found to be dissociated preferentially from Bcl-XL in HCT116 cells but not in the PUMA-knockout cells, in response to PUMA induction and adriamycin treatment. PUMA inhibited the association of Bax and Bcl-XL in vitro by directly binding to Bcl-XL through its BH3 domain. Finally, we found that wild-type Bax, but not mutant Bax deficient in either multimerization or mitochondrial localization, was able to restore PUMA-induced apoptosis in the BAX-knockout cells. Together, these results indicate that PUMA initiates apoptosis in part by dissociating Bax and Bcl-XL, thereby promoting Bax multimerization and mitochondrial translocation.


Received for publication, December 21, 2005 , and in revised form, March 15, 2006.

* This work was supported by Grant CA106348 from the National Institutes of Health (to L. Z.), grants from the Edward Mallinckrodt Jr. Foundation and the Elsa U. Pardee Foundation (to L. Z.), and grants from the Flight Attendant Medical Research Institute and the Hillman Foundation (to J. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Scholar of the General Motors Cancer Research Foundation and the V Foundation for Cancer Research. To whom correspondence should be addressed: UPCI Research Pavilion, Rm. 2.42d, Hillman Cancer Center, 5117 Centre Ave., University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213. Tel.: 412-623-1009; Fax: 412-623-7778; E-mail: zhanglx{at}upmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
Y. Zhang, D. Xing, and L. Liu
PUMA Promotes Bax Translocation by Both Directly Interacting with Bax and by Competitive Binding to Bcl-XL during UV-induced Apoptosis
Mol. Biol. Cell, July 1, 2009; 20(13): 3077 - 3087.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Qiu, E. B. Carson-Walter, S. F. Kuan, L. Zhang, and J. Yu
PUMA Suppresses Intestinal Tumorigenesis in Mice
Cancer Res., June 15, 2009; 69(12): 4999 - 5006.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
T. Gallenne, F. Gautier, L. Oliver, E. Hervouet, B. Noel, J. A. Hickman, O. Geneste, P.-F. Cartron, F. M. Vallette, S. Manon, et al.
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
J. Cell Biol., April 20, 2009; 185(2): 279 - 290.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Ming, T. Sakaida, W. Yue, A. Jha, L. Zhang, and J. Yu
Sp1 and p73 activate PUMA following serum starvation
Carcinogenesis, October 1, 2008; 29(10): 1878 - 1884.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Yue, Q. Sun, S. Dacic, R. J. Landreneau, J. M. Siegfried, J. Yu, and L. Zhang
Downregulation of Dkk3 activates {beta}-catenin/TCF-4 signaling in lung cancer
Carcinogenesis, January 1, 2008; 29(1): 84 - 92.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Q. Sun, T. Sakaida, W. Yue, S. M. Gollin, and J. Yu
Chemosensitization of head and neck cancer cells by PUMA
Mol. Cancer Ther., December 1, 2007; 6(12): 3180 - 3188.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Yue, S. Dacic, Q. Sun, R. Landreneau, M. Guo, W. Zhou, J. M. Siegfried, J. Yu, and L. Zhang
Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation
Clin. Cancer Res., August 1, 2007; 13(15): 4336 - 4344.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Wang, J. Yu, and L. Zhang
The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage
PNAS, March 6, 2007; 104(10): 4054 - 4059.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
W.-X. Ding, H.-M. Ni, X. Chen, J. Yu, L. Zhang, and X.-M. Yin
A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells
Mol. Cancer Ther., March 1, 2007; 6(3): 1062 - 1069.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. N. Willis, J. I. Fletcher, T. Kaufmann, M. F. van Delft, L. Chen, P. E. Czabotar, H. Ierino, E. F. Lee, W. D. Fairlie, P. Bouillet, et al.
Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak
Science, February 9, 2007; 315(5813): 856 - 859.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Castilla, B. Congregado, D. Chinchon, F. J. Torrubia, M. A. Japon, and C. Saez
Bcl-xL Is Overexpressed in Hormone-Resistant Prostate Cancer and Promotes Survival of LNCaP Cells via Interaction with Proapoptotic Bak
Endocrinology, October 1, 2006; 147(10): 4960 - 4967.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement